• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡维地洛在果糖诱导的高血压大鼠中的药代动力学和药效学特性。

Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.

作者信息

Bertera Facundo, Di Verniero Carla Andrea, Mayer Marcos Alejandro, Chiappetta Diego, Buontempo Fabián, Polizio Ariel Héctor, Taira Carlos Alberto, Höcht Christian

机构信息

Department of Pharmacology, School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina.

出版信息

Xenobiotica. 2012 Feb;42(2):206-19. doi: 10.3109/00498254.2011.604746. Epub 2011 Sep 5.

DOI:10.3109/00498254.2011.604746
PMID:21892881
Abstract

Cardiovascular effects and pharmacokinetics of carvedilol were assessed in fructose-fed rats using pharmacokinetic-pharmacodynamic (PK-PD) modeling. Male Sprague-Dowley rats were randomly assigned to receive tap water (C rats) or fructose solution (10% w/v) (F rats) during 6 weeks. Effects of carvedilol (1-3 mg/kg i.v.) on blood pressure, heart rate and blood pressure variability were recorded. Carvedilol plasma pharmacokinetics was studied by traditional blood sampling. Relationship between carvedilol concentrations and their hypotensive and bradycardic effects was established by PK-PD modeling. Vascular sympatholytic activity of carvedilol was assessed by estimation of drug effects on low frequency blood pressure variability using spectral analysis. A greater volume of distribution and clearance of S-carvedilol compared to R-enantiomer was found in both experimental groups. Although PK-PD properties of S-carvedilol chronotropic effect were not altered in F rats, hypertensive rats showed greater efficacy to the carvedilol hypotensive response after administration of the higher dose. A similar potency of carvedilol to inhibit sympathetic vascular activity was found in F rats. Carvedilol showed enantioselective pharmacokinetic properties with increased distribution in F rats compared with normotensive animals. An enhanced hypotensive activity of carvedilol was found in F rats compared with C rats, which is not related to enhance sympatholytic activity.

摘要

使用药代动力学 - 药效学(PK - PD)模型,在喂食果糖的大鼠中评估了卡维地洛的心血管效应和药代动力学。雄性Sprague - Dowley大鼠在6周内随机分为两组,分别饮用自来水(C组大鼠)或果糖溶液(10% w/v)(F组大鼠)。记录卡维地洛(1 - 3mg/kg静脉注射)对血压、心率和血压变异性的影响。通过传统的采血方法研究卡维地洛的血浆药代动力学。通过PK - PD模型建立卡维地洛浓度与其降压和减慢心率作用之间的关系。使用频谱分析估计药物对低频血压变异性的影响,评估卡维地洛的血管交感神经溶解活性。在两个实验组中,均发现S - 卡维地洛的分布容积和清除率比R - 对映体更大。虽然F组大鼠中S - 卡维地洛变时作用的PK - PD特性未改变,但高血压大鼠在给予较高剂量后对卡维地洛的降压反应显示出更大的疗效。在F组大鼠中发现卡维地洛抑制交感神经血管活性的效力相似。与正常血压动物相比,卡维地洛在F组大鼠中表现出对映选择性药代动力学特性,分布增加。与C组大鼠相比,F组大鼠中卡维地洛的降压活性增强,这与交感神经溶解活性增强无关。

相似文献

1
Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.卡维地洛在果糖诱导的高血压大鼠中的药代动力学和药效学特性。
Xenobiotica. 2012 Feb;42(2):206-19. doi: 10.3109/00498254.2011.604746. Epub 2011 Sep 5.
2
Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.硝苯地平控释片治疗原发性高血压的药代动力学及药效学研究。
J Pharm Pharmacol. 2010 Jul;62(7):890-900. doi: 10.1211/jpp.62.07.0010.
3
Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability.卡维地洛在自发性高血压大鼠中的对映选择性药代动力学和药效动力学特性:关注血压变异性。
Naunyn Schmiedebergs Arch Pharmacol. 2012 Mar;385(3):325-35. doi: 10.1007/s00210-011-0698-7. Epub 2011 Nov 3.
4
Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol.乌拉坦-氯醛糖麻醉是否适用于药代动力学-药效学评估?卡维地洛的研究。
J Pharmacol Toxicol Methods. 2009 Jan-Feb;59(1):13-20. doi: 10.1016/j.vascn.2008.10.001. Epub 2008 Nov 1.
5
Comparison of different pharmacodynamic models for pharmacokinetic-pharmacodynamic (PK-PD) modeling of carvedilol.卡维地洛药代动力学-药效学(PK-PD)建模中不同药效学模型的比较。
Yao Xue Xue Bao. 2009 Apr;44(4):406-11.
6
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics.卡维地洛的药代动力学和药效学与 CYP2D6 和 ADRB 药物遗传学的关系。
Pharmacogenomics. 2011 Jun;12(6):783-95. doi: 10.2217/pgs.11.20. Epub 2011 May 23.
7
In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats.美托洛尔在喂食果糖的高血压大鼠体内和体外的药效学特性
J Cardiovasc Pharmacol. 2008 Jun;51(6):532-41. doi: 10.1097/FJC.0b013e3181730306.
8
Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.长期使用卡维地洛可降低易患高血压性中风大鼠的死亡率和肾损伤。
J Pharmacol Exp Ther. 1996 Nov;279(2):948-55.
9
Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.高血压患者中,控释卡维地洛与速释卡维地洛在稳态时的药代动力学和药效学比较。
Am J Cardiol. 2006 Oct 2;98(7A):17L-26L. doi: 10.1016/j.amjcard.2006.07.015. Epub 2006 Aug 28.
10
Pharmacokinetics of carvedilol in older and younger patients.卡维地洛在老年和年轻患者中的药代动力学。
J Hum Hypertens. 1990 Dec;4(6):709-15.

引用本文的文献

1
Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.比索洛尔对自发性高血压大鼠的逐搏血压及短期血压变异性的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2012 Aug;385(8):833-43. doi: 10.1007/s00210-012-0756-9. Epub 2012 May 9.
2
Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability.卡维地洛在自发性高血压大鼠中的对映选择性药代动力学和药效动力学特性:关注血压变异性。
Naunyn Schmiedebergs Arch Pharmacol. 2012 Mar;385(3):325-35. doi: 10.1007/s00210-011-0698-7. Epub 2011 Nov 3.